Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

Authors: Kekitiinwa AR, Meda M, Jennings A, Bwakura-Dangarembizi M, Kityo C, Siika A, Archary M, Green A, Jafta L, Akabwai GP, Mujuru HA, Mugerwa H, Kiilu C, Mngqibisa R, Seeley J, Nazzinda R, Apoto N, Walker S, Burger D, Giaquinto C, Okello RB, Musoro G, Wambui C, Arumugam T, Conway M, Van Looy N, South A, Bamford A, Thomason MJ, Ford D, Pett SL, on behalf of the BREATHER Plus Trial Team

Published in: The Lancet HIV